1 option
The High Price of Aduhelm's Approval An Investigation into FDA's Atypical Review Process and Biogen's Aggressive Launch Plans
ProQuest Congressional Research Digital Collection: Part C (2011 forward) Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on Oversight and Reform, issuing body.
- Language:
- English
- Subjects (All):
- United States. Food and Drug Administration.
- United States.
- Biogen, Inc.
- Alzheimer's disease--Treatment--United States.
- Alzheimer's disease.
- Drug approval--Government policy--United States.
- Drug approval.
- Physical Description:
- 1 online resource
- Contained In:
- ProQuest U.S. Congressional Research Digital Collection
- Place of Publication:
- Bethesda, Md. ProQuest 2022
- Notes:
- "Dec. 2022"
- Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection. Reuse of record except for individual research requires license from ProQuest, LLC
- Vendor supplied data
- Publisher Number:
- cmp20230735
- crdccmp2022cor234719
- CMP-2022-COR-234719
- Access Restriction:
- Restricted for use by site license
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.